What is the recommended treatment for a premature infant with retinopathy of prematurity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Retinopathy of Prematurity

For premature infants with threshold ROP, peripheral retinal ablation using laser photocoagulation is the definitive treatment that has proven effective in reducing blindness. 1

Treatment Modalities by Disease Severity

Threshold ROP (Treatment-Requiring Disease)

  • Laser photocoagulation is the standard treatment, particularly for disease located in Zone II 2
  • Peripheral ablation (cryotherapy or laser therapy) destroys avascular retinal tissue to prevent progression to blindness 3, 1
  • Anti-vascular endothelial growth factor (anti-VEGF) agents are increasingly used as monotherapy or adjunct to laser, especially for Zone I disease 2
  • The choice between laser alone versus anti-VEGF depends on disease location, with Zone I disease favoring anti-VEGF consideration 2

Pre-threshold ROP

  • Oral propranolol shows encouraging results for prevention and treatment of pre-threshold disease, though this represents emerging evidence 2
  • Close monitoring with ophthalmology visits every 1-2 weeks is required for infants whose vessels or ROP remain in Zone I or Zone II 1

Advanced Disease (Stages 4-5)

  • Retinal detachment repair may be attempted, though visual outcomes are disappointing with 93.6% of eyes achieving visual acuity of 3/60 or less 4
  • Surgical intervention is often required for complications including cataract (54.8% of advanced cases), glaucoma (22.6%), and microphthalmos (48.4%) 4

Critical Oxygen Management During Treatment

Oxygen control differs based on the infant's retinal vascular status and disease phase:

For Infants with Incomplete Retinal Vascularization

  • Avoid sustained hyperoxemia, as high arterial oxygen levels slow normal vascularization during the vaso-obliteration phase 5
  • Marginally low oxygen aggravates neovascularization during Phase II, requiring careful balance 5, 1
  • The STOP-ROP trial demonstrated that oxygen saturation targets of 96-99% do not increase risk of ROP progression in infants with pre-threshold disease 3, 6

For Infants with Complete Retinal Vascularization

  • Once retinal vessels have grown to the ora serrata (fully vascularized), the retina is considered "safe" from mildly elevated arterial oxygen levels 3
  • Target oxygen saturation of 95% or higher is recommended to prevent pulmonary complications 6, 1
  • This applies to infants who have undergone peripheral retinal ablation, as they have no residual avascular retina 3

Follow-Up Requirements

Missing follow-up appointments represents the greatest risk for preventable vision loss 6, 1

High-Risk Infants Requiring Frequent Monitoring

  • Infants with vessels or ROP still in Zone I or Zone II need ophthalmology visits every 1-2 weeks 6, 1
  • Infants with chronic lung disease of infancy require careful coordination of follow-up appointments, as parents cannot usually provide close oxygen control at home without extensive support 3, 6

Safe to Discontinue Screening

  • ROP that is regressing with vessels passed into Zone III on at least two sequential examinations is extremely unlikely to progress to threshold 6, 1
  • Complete retinal vascularization indicates screening can be discontinued 6, 1

Common Pitfalls to Avoid

  • Delayed transfer for treatment: Infants transferred from other facilities often present beyond threshold ROP (80% in one series), missing the optimal treatment window 4
  • Inadequate home oxygen monitoring: Parents cannot be expected to provide close oxygen control without extensive support, potentially leading to ROP worsening 3
  • Screening infants >37 weeks gestation: These infants do not require screening unless they have chronic lung disease 6
  • Using general ophthalmologists for screening: Only pediatric ophthalmologists skilled in evaluating the premature infant retina should perform examinations 6

References

Guideline

Treatment and Management of Retinopathy of Prematurity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update in the Treatment of Retinopathy of Prematurity.

American journal of perinatology, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pathophysiology of Retinopathy of Prematurity in Preterm Neonates

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Timing of First ROP Screening Examination in Newborns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.